The Risk of Falls Index for Patients With Neuromuscular Disorders

Rekrutierend

Studienbeginn:
September 2023

Letztes Update:
11.10.2023

Wirkstoff:
-

Indikation (Clinical Trials):
Myasthenia Gravis, Muscular Dystrophies, Myositis, Myotonic Dystrophy, Myositis, Inclusion Body, Muscular Dystrophy, Facioscapulohumeral, Neuromuscular Diseases

Geschlecht:
Alle

Altersgruppe:
Erwachsene (18+)

Phase:
-

Sponsor:
LMU Klinikum

Collaborator:
-

Kontakt

Marko Mijic
Kontakt:
Phone: +4989440057078
E-Mail: marko.mijic@med.uni-muenchen.de» Kontaktdaten anzeigen

Corinna Wirner-Piotrowski
Kontakt:
E-Mail: Corinna.Wirner@med.uni-muenchen.de» Kontaktdaten anzeigen

Studienlocations
(1 von 1)

Marko Mijic
80336 München
(Bayern)
GermanyRekrutierend» Google-Maps
Ansprechpartner:
Marko Mijic
E-Mail: marko.mijic@med.uni-muenchen.de

Corinna Wirner-Piotrowski
E-Mail: Corinna.Wirner@med.uni-muenchen.de» Ansprechpartner anzeigen

Studien-Informationen

Brief Summary:

The combination of short quantitatively assessing muscular function and balance in

combination with short clinical scores, can be a new valid approach to evaluate the patient

risk of fall and help to create a quick checkup test to prescribe an appropriate assistive

device.

The primary goal of this project is to provide a short battery of clinical assessments used

to determine risk of falling for patients with neuromuscular diseases (NMD) based on

correlation between clinical assessments between two groups of NMD patients and scales used

to assess risk of falling for patients.

Ein-/Ausschlusskriterien

Inclusion Criteria:

- Patients between 18- and 65-year-old

- Patients with adequate cognitive and communication function to fill out the scales

assessing risk of falling

- The neuromuscular disease needs to be confirmed by genetic report and/or disease

deepening neurophysiological examination.

Exclusion Criteria:

- Patients which are not able to perform motoric functional assessments without assistive

gait device.

Studien-Rationale

Primary outcome:

1. FBIndex (Time Frame - 2 years):
The primary goal of this project is to provide a short battery of clinical assessments used to determine risk of falling for patients with NMDs based on correlation between clinical assessments: Heel-Rise-Test, Chair-Rise Test, Semi-tandem stand, Trunk Rise Test, and Foot-tapping speed, Timed Up and Go test, 10 Meter Walk Test and Six Minute Walk test, between two groups of NMD patients and scales: "The Falls Efficacy Scale International FES-I" and "The Morse Fall Scale" used to assess risk of falling for patients.

Geprüfte Regime

The risk of falls:
Heel-Rise-Test, Chair-Rise Test, Semi-tandem stand, Trunk Rise Test, and Foot-tapping speed. Test battery two includes Timed Up and Go test, 10 Meter Walk Test, Six Minute Walk test, The Falls Efficacy Scale International FES-I, The Morse Fall Scale.

Quelle: ClinicalTrials.gov